FEDEX CORP Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Fedex Corp quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2019 to Q3 2024.
  • Fedex Corp Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending August 31, 2024 was $3.67B, a 15.8% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.67B +$501M +15.8% Aug 31, 2024 10-Q 2024-09-19
Q2 2024 $3.63B +$564M +18.4% May 31, 2024 10-K 2024-07-15
Q1 2024 $3.09B +$127M +4.28% Feb 29, 2024 10-Q 2024-03-21
Q4 2023 $3.15B +$394M +14.3% Nov 30, 2023 10-Q 2023-12-19
Q3 2023 $3.17B +$431M +15.7% Aug 31, 2023 10-Q 2023-09-20
Q2 2023 $3.07B +$606M +24.6% May 31, 2023 10-K 2023-07-17
Q1 2023 $2.97B +$500M +20.3% Feb 28, 2023 10-Q 2023-03-16
Q4 2022 $2.76B +$289M +11.7% Nov 30, 2022 10-Q 2022-12-20
Q3 2022 $2.74B +$291M +11.9% Aug 31, 2022 10-Q 2022-09-22
Q2 2022 $2.46B -$59M -2.34% May 31, 2022 10-K 2022-07-18
Q1 2022 $2.47B +$42M +1.73% Feb 28, 2022 10-Q 2022-03-17
Q4 2021 $2.47B +$94M +3.96% Nov 30, 2021 10-Q 2021-12-16
Q3 2021 $2.45B -$30M -1.21% Aug 31, 2021 10-Q 2021-09-21
Q2 2021 $2.52B +$59M +2.4% May 31, 2021 10-K 2021-07-19
Q1 2021 $2.42B -$114M -4.49% Feb 28, 2021 10-Q 2021-03-18
Q4 2020 $2.38B -$240M -9.18% Nov 30, 2020 10-Q 2020-12-17
Q3 2020 $2.48B -$322M -11.5% Aug 31, 2020 10-Q 2020-09-15
Q2 2020 $2.46B May 31, 2020 10-K 2020-07-20
Q1 2020 $2.54B Feb 29, 2020 10-Q 2020-03-17
Q4 2019 $2.62B Nov 30, 2019 10-Q 2019-12-17
Q3 2019 $2.8B Aug 31, 2019 10-Q 2019-09-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.